Results 341 to 350 of about 1,451,429 (415)

Facial reconstruction with implants of porous polyethylene [PDF]

, 1985
Berghaus, Alexander, Myers, Eugene N.
core  

Recent developments in diagnosis and treatment of nasopharyngeal carcinoma.

, 1991
Tai-Fu Liu
openalex  

AMBRA1 Inhibits Non‐Small Cell Lung Cancer Progression Through miR‐1178/p53/CDK2‐Regulated Cell Cycle Arrest

Journal of Cellular and Molecular Medicine, Volume 29, Issue 11, June 2025.
ABSTRACT AMBRA1 is associated with a variety of pathological processes in cancer cells, but may have different functions in different tumour microenvironments or genetic backgrounds. In this study, the function and regulatory mechanisms of AMBRA1 were explored in the progression of non‐small cell lung cancer (NSCLC).
Jing Feng, Shan Li, Laihua Li, Zhiqiang Du, Guangying Yang, Zhi Zhao, Xueke Fan, Na Wang, Zhigang Zhao   +8 more
wiley   +1 more source

Interventional Treatment Strategies for Carotid Blowout Syndrome After Radiotherapy for Nasopharyngeal Carcinoma. [PDF]

Cancer Manag Res
Lin Z, Chen J, Zou X, Zhang J, Huang D.
europepmc   +1 more source

Nasopharyngeal necrosis following intensity-modulated radiation therapy of primary nasopharyngeal carcinoma-incidence rate and predictors of risk. [PDF]

BMC Cancer
Yang XL, Lin L, He SS, Wen DW, Kou J, Wang Y, Wang XC, Chen Y.   +7 more
europepmc   +1 more source

Reduced‐volume radiotherapy versus conventional‐volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open‐label, noninferiority, multicenter, randomized phase 3 trial

CA: A Cancer Journal for Clinicians, Volume 75, Issue 3, Page 203-215, May/June 2025.
Abstract Background Nearly 90% locoregionally advanced nasopharyngeal carcinoma (LANPC) responds to induction chemotherapy (IC) with significant tumor volume shrinkage. Radiotherapy always follows IC, and reduced volume has been proposed. However, the efficacy and safety of reduced‐volume radiotherapy is uncertain.
Ling‐Long Tang, Lin Chen, Gui‐Qiong Xu, Ning Zhang, Cheng‐Long Huang, Wen‐Fei Li, Yan‐Ping Mao, Guan‐Qun Zhou, Feng Lei, Lu‐Si Chen, Shao Hui Huang, Lei Chen, Yu‐Pei Chen, Yuan Zhang, Xu Liu, Cheng Xu, Yin Zhao, Ji‐Bin Li, Na Liu, Fang‐Yun Xie, Rui Guo, Ying Sun, Jun Ma   +22 more
wiley   +1 more source

Patient Characteristics and Treatment Outcomes of Nasopharyngeal Carcinoma in Nonendemic Regions.

JAMA Netw Open
Alsavaf MB, Marquardt M, Abouammo MD, Xu M, Elguindy A, Grecula J, Baliga S, Konieczkowski D, Gogineni E, Bhateja P, Rocco JW, Old MO, Blakaj DM, Carrau RL, VanKoevering KK, Bonomi M.   +15 more
europepmc   +1 more source

Pre-treatment and post-treatment nasopharyngeal carcinoma imaging: imaging updates, pearls and pitfalls. [PDF]

Neuroradiology
Li KY, Kwok HM, Pan NY, Cheng LF, Ma KFJ.   +4 more
europepmc   +1 more source

Synergistic PD‐1/LAG‐3 Inhibition: Mechanistic Insights and Implications for Enhanced Tumor Immunotherapy

MedComm, Volume 6, Issue 6, June 2025.
Jianqiao Shentu, Hening Xu, Shiwei Duan
wiley   +1 more source

Beyond fluorodeoxyglucose: Molecular imaging of cancer in precision medicine

CA: A Cancer Journal for Clinicians, Volume 75, Issue 3, Page 226-242, May/June 2025.
Abstract Cancer molecular imaging is the noninvasive visualization of a process unique to or altered in neoplasia, such as proliferation, glucose metabolism, and receptor expression, which is relevant to patient management. Several molecular imaging modalities are now available, including magnetic resonance, optical, and nuclear imaging.
Malik E. Juweid, Soud F. Al‐Qasem, Fadlo R. Khuri, Andrea Gallamini, Philipp Lohmann, Hans‐Joachim Ziellenbach, Felix M. Mottaghy   +6 more
wiley   +1 more source